RA
LMAT icon

Royce & Associates’s LeMaitre Vascular LMAT Stock Holding History

Royce & Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$391K Buy
+3,582
New +$341K ﹤0.01% 722
2024
Q1 		– Sell
-9,200
Closed -$522K – 908
2023
Q4 		$522K Buy
+9,200
New +$482K ﹤0.01% 789
2022
Q4 		– Sell
-5,134
Closed -$260K – 935
2022
Q3 		$260K Sell
5,134
-3,737
-42% -$187K ﹤0.01% 875
2022
Q2 		$404K Buy
8,871
+114
+1% +$5.1K ﹤0.01% 856
2022
Q1 		$407K Buy
+8,757
New +$392K ﹤0.01% 899
2021
Q2 		– Sell
-14,620
Closed -$713K – 1027
2021
Q1 		$713K Sell
14,620
-5,020
-26% -$235K ﹤0.01% 892
2020
Q4 		$795K Buy
19,640
+4,216
+27% +$151K 0.01% 837
2020
Q3 		$502K Buy
15,424
+5,368
+53% +$161K 0.01% 861
2020
Q2 		$265K Buy
10,056
+4,027
+67% +$105K ﹤0.01% 912
2020
Q1 		$150K Buy
6,029
+83
+1% +$2.56K ﹤0.01% 949
2019
Q4 		$214K Sell
5,946
-64
-1% -$2.21K ﹤0.01% 966
2019
Q3 		$205K Buy
6,010
+199
+3% +$6.36K ﹤0.01% 975
2019
Q2 		$163K Buy
5,811
+40
+0.7% +$1.11K ﹤0.01% 997
2019
Q1 		$179K Sell
5,771
-75,876
-93% -$2.02M ﹤0.01% 1001
2018
Q4 		$1.93M Buy
81,647
+14,009
+21% +$383K 0.02% 741
2018
Q3 		$2.62M Sell
67,638
-15,736
-19% -$567K 0.02% 771
2018
Q2 		$2.79M Buy
83,374
+39,683
+91% +$1.41M 0.02% 755
2018
Q1 		$1.58M Buy
43,691
+38,471
+737% +$1.33M 0.01% 893
2017
Q4 		$166K Buy
5,220
+51
+1% +$1.75K ﹤0.01% 1091
2017
Q3 		$193K Buy
5,169
+169
+3% +$5.75K ﹤0.01% 1072
2017
Q2 		$156K Buy
+5,000
New +$144K ﹤0.01% 1084
2015
Q4 		– Sell
-9,900
Closed -$121K – 1150
2015
Q3 		$121K Hold
9,900
– – ﹤0.01% 1121
2015
Q2 		$119K Hold
9,900
– – ﹤0.01% 1148
2015
Q1 		$83K Buy
+9,900
New +$77.7K ﹤0.01% 1167

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Royce & Associates's LMAT Position: Q1 2026 in Review

Royce & Associates opened a new position in LeMaitre Vascular (LMAT) in Q1 2026: 3,582 shares worth $391K. The stake represents ﹤0.01% of the portfolio and ranks #722 among its holdings. This is a return to the name: Royce & Associates previously reported a position in LMAT as recently as Q4 2023.

Royce & Associates first reported a position in LMAT in Q1 2015 and has held it in 24 quarters since. The position peaked at $2.79M in Q2 2018. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Royce & Associates held 3,582 shares of LeMaitre Vascular worth $391K as of Q1 2026.
  • LeMaitre Vascular was a new Royce & Associates position in Q1 2026.
  • LeMaitre Vascular made up ﹤0.01% of Royce & Associates's portfolio in Q1 2026, its #722 holding.
  • Royce & Associates first reported a position in LeMaitre Vascular in Q1 2015 and has held it in 24 quarters since.
  • Royce & Associates's LeMaitre Vascular position peaked at $2.79M in Q2 2018.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.